New Mexico § 33-2-51 Discharge; opioid use disorder; opioid overdose

New Mexico Statutes

§ 33-2-51 — Discharge; opioid use disorder; opioid overdose

New Mexico § 33-2-51

Ch. 33Correctional Institutions

Art. 2State Correctional Facilities

This text of New Mexico § 33-2-51 (Discharge; opioid use disorder; opioid overdose) is published on Counsel Stack Legal Research, covering New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.M. Stat. Ann. § 33-2-51 (2026).

Text

education; naloxone. A. As corrections department funding and department supplies of naloxone permit, upon discharge of an inmate who has been diagnosed with an opioid use disorder from a corrections facility, regardless of whether that inmate has received treatment for that disorder, the corrections department shall:

(1)ensure that the inmate is provided with opioid overdose education that:

(a)conforms to department of health or federal substance abuse and mental health services administration guidelines for opioid overdose education;

(b)explains the causes of an opioid overdose;

(c)instructs when and how to administer in accordance with medical best practices: 1) life-saving rescue techniques; and 2) an opioid antagonist; and (d) explains how to contact appropriate emergency medical

Free access — add to your briefcase to read the full text and ask questions with AI

education; naloxone. A. As corrections department funding and department supplies of naloxone permit, upon discharge of an inmate who has been diagnosed with an opioid use disorder from a corrections facility, regardless of whether that inmate has received treatment for that disorder, the corrections department shall: (1) ensure that the inmate is provided with opioid overdose education that: (a) conforms to department of health or federal substance abuse and mental health services administration guidelines for opioid overdose education; (b) explains the causes of an opioid overdose; (c) instructs when and how to administer in accordance with medical best practices: 1) life-saving rescue techniques; and 2) an opioid antagonist; and (d) explains how to contact appropriate emergency medical services; and (2) provide the inmate, as the inmate leaves the correctional facility, with: (a) two doses of naloxone in either a generic form or in a form approved by the federal food and drug administration; and (b) a prescription for naloxone. B. As used in this section: (1) "corrections facility" means a prison or other detention facility, whether operated by a government or private contractor, that is used for confinement of adult or juvenile persons who are charged with or convicted of a violation of a law or an ordinance; and (2) "naloxone" means naloxone hydrochloride, which is an opioid antagonist for the treatment of an opioid overdose.